Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axelle Dupont

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Pediatric Blood & Cancer|October 24, 2020
Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcomeIda Russo, Christine Levy-Gabriel, Axelle Dupont, et al.
Journal of the American Heart Association|December 21, 2018
Long-Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 PatientsAlexandre Le Joncour, Simon Soudet, Axelle Dupont, et al.
Journal of Hematology & Oncology|May 21, 2020
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)Anne-Claire Mamez, Axelle Dupont, Didier Blaise, et al.
Plos One|August 3, 2018
Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a monthDaniel Eyraud, Ludovic Suner, Axelle Dupont, et al.
Ebiomedicine|September 25, 2025
Higher levels of host-cell DNA methylation markers ZNF582 and ASCL1 on anal smears are predictive for progression to anal cancer in patients with previous high-grade lesionsValentine Marie Ferré, Axelle Dupont, Mélanie Draullette, et al.
Jac-Antimicrobial Resistance|March 6, 2025
National expert consensus on the management of antibiotic prophylaxis in surgical patients with a penicillin allergy label based on the Delphi methodAurélie Gouel-Chéron, Catherine Neukirch, Annick Barbaud, et al.
The Pediatric Infectious Disease Journal|May 20, 2026
SARS-CoV-2 Reinfection and Risk of Multisystem Inflammatory Syndrome in Children: A Case-Control StudyNoémie Schiever, Léa Lenglart, Corinne Levy, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 19, 2024
Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineagesJean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, et al.
Scientific Reports|April 24, 2025
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trialDavid M Smadja, Clément R Massonnaud, Aurélien Philippe, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 28, 2021
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Pediatric Blood & Cancer|October 24, 2020
Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcomeIda Russo, Christine Levy-Gabriel, Axelle Dupont, et al.
Journal of the American Heart Association|December 21, 2018
Long-Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 PatientsAlexandre Le Joncour, Simon Soudet, Axelle Dupont, et al.
Journal of Hematology & Oncology|May 21, 2020
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)Anne-Claire Mamez, Axelle Dupont, Didier Blaise, et al.
Plos One|August 3, 2018
Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a monthDaniel Eyraud, Ludovic Suner, Axelle Dupont, et al.
Ebiomedicine|September 25, 2025
Higher levels of host-cell DNA methylation markers ZNF582 and ASCL1 on anal smears are predictive for progression to anal cancer in patients with previous high-grade lesionsValentine Marie Ferré, Axelle Dupont, Mélanie Draullette, et al.
Jac-Antimicrobial Resistance|March 6, 2025
National expert consensus on the management of antibiotic prophylaxis in surgical patients with a penicillin allergy label based on the Delphi methodAurélie Gouel-Chéron, Catherine Neukirch, Annick Barbaud, et al.
The Pediatric Infectious Disease Journal|May 20, 2026
SARS-CoV-2 Reinfection and Risk of Multisystem Inflammatory Syndrome in Children: A Case-Control StudyNoémie Schiever, Léa Lenglart, Corinne Levy, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 19, 2024
Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineagesJean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, et al.
Scientific Reports|April 24, 2025
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trialDavid M Smadja, Clément R Massonnaud, Aurélien Philippe, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 28, 2021
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, et al.
Pageof 3